NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
19. März 2019 18:33 ET
|
NanoString Technologies, Inc.
SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Technologies Announces Commencement of Public Offering of Common Stock
18. März 2019 16:18 ET
|
NanoString Technologies, Inc.
SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Technologies Releases Fourth Quarter and Full Year 2018 Operating Results and Provides 2019 Outlook
07. März 2019 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, March 07, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported...
NanoString to Present at the 39th Annual Cowen Healthcare Conference
04. März 2019 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, March 04, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today...
NanoString Showcases GeoMx and Hyb & Seq Platforms at 2019 Advances in Genome Biology and Technology (AGBT) Conference
27. Februar 2019 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Feb. 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString to Host Inaugural Spatial Genomics Summit on Wednesday, February 27th at the 2019 Advances in Genome Biology and Technology (AGBT) Conference
25. Februar 2019 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Feb. 25, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString to Release Fourth Quarter and Fiscal Year 2018 Financial Results and Host Conference Call on Thursday, March 7, 2019
21. Februar 2019 09:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Feb. 21, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2018
06. Januar 2019 20:00 ET
|
NanoString Technologies, Inc.
— FY18 Product and Service Revenue of $83.5 million, Exceeding High-End of Guidance —— Generated Pre-Orders for More Than 30 GeoMx™ Digital Spatial Profilers — SEATTLE, Jan. 06, 2019 (GLOBE...
NanoString to Present at the 37th Annual J.P. Morgan Healthcare Conference
21. Dezember 2018 07:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Dec. 21, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
United Kingdom’s National Institute for Health and Care Excellence (NICE) Recommends NanoString’s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualified Early-Stage Invasive Breast Cancer Patients
19. Dezember 2018 16:01 ET
|
NanoString Technologies, Inc.
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...